脂质纳米颗粒封装的线粒体修复大鼠面神经损伤的实验研究

Repair of facial nerve injury in rats with lipid nanoparticles-encapsulated mitochondria

  • 摘要: 背景 面神经损伤早期线粒体功能障碍限制其修复进度,优化递送策略以提升线粒体移植疗效是当前研究重点。目的 本研究拟构建一种由脂质纳米颗粒(lipid nanoparticles,LNP)封装的工程化线粒体(Mito@LNP),并评估其在大鼠面神经颊支挤压损伤模型中的修复作用。方法 采用薄膜水化-挤出法制备LNP,并从人脐带间充质干细胞(human umbilical cord mesenchymal stem cells,hUCMSC)提取线粒体,制备出LNP 封装的线粒体(Mito@LNP)。通过PC12 细胞进行体外实验,检测LNP封装体系的细胞毒性、摄取效率及其对H2O2诱导的氧化损伤的保护能力。建立大鼠面神经颊支挤压损伤模型,在损伤处局部束膜下注射Mito@LNP。利用小动物活体成像示踪线粒体体内分布,并通过胡须运动分析、神经电生理检测及免疫荧光染色,评估其神经修复作用。结果 成功制备Mito@LNP,线粒体封装效率达89.4%。与游离线粒体相比,LNP 能提高PC12 细胞对线粒体的摄取效率(P<0.05)。在氧化应激条件下,相比游离线粒体,Mito@LNP 更能有效维持PC12 细胞ATP生成(P<0.001)及线粒体膜电位(P<0.05),提升细胞存活率(P<0.05)。体内示踪表明,Mito@LNP 在神经损伤部位的滞留与富集能力更强(P<0.05)。接受Mito@LNP 治疗的大鼠,其胡须运动功能(P<0.001)及复合肌肉动作电位(compound muscle action potential,CMAP) 恢复情况(P<0.05) 均明显优于游离线粒体治疗组。免疫荧光染色显示,Mito@LNP能上调损伤神经组织中NF200(P<0.001)和S100β(P<0.05)的表达。结论 Mito@LNP 通过提升线粒体递送效率,促进了大鼠面神经挤压伤后的修复及功能重建,疗效优于游离线粒体。

     

    Abstract: Background Since early mitochondrial dysfunction constrains facial nerve regeneration, improving the therapeutic outcomes of mitochondrial transplantation through optimized delivery methods has become a primary research focus.Objective To construct lipid nanoparticles (LNP)-encapsulated engineered mitochondria (Mito@LNP) and evaluate their reparative effects in a rat buccal branch facial nerve crush injury model.Methods LNP was prepared by thin film hydration-extrusion method. Mitochondria were isolated from human umbilical cord mesenchymal stem cells (hUCMSC) and formulated into Mito@LNP. In vitro, PC12 cells were used to assess cytotoxicity, cellular uptake, and protection against H₂O₂-induced oxidative damage. In vivo, a rat buccal branch facial nerve crush model was established, and Mito@LNP was administered locally via subepineurial injection at the injury site. Small animal in vivo optical imaging system was employed to track mitochondrial distribution. Whisker movement analysis, electrophysiological testing, and immunofluorescence staining were performed to evaluate evaluate its neural repair effects.Results  Mito@LNP was successfully fabricated, achieving a mitochondrial encapsulation efficiency of 89.4%. Compared with free mitochondria, LNP encapsulation enhanced mitochondrial uptake by PC12 cells (P<0.05). Under oxidative stress, Mito@LNP more effectively maintained ATP production (P<0.001) and mitochondrial membrane potential (P<0.05) in PC12 cells, thereby markedly improving cell viability (P<0.05). In vivo tracking indicated stronger retention and accumulation of Mito@LNP at the injured nerve (P<0.05). Rats treated with Mito@LNP showed substantially better recovery of whisker function (P<0.001) and compound muscle action potential (CMAP) parameters (P<0.05) than those receiving free mitochondria. Immunofluorescence staining further demonstrated that Mito@LNP significantly upregulated NF200 (P<0.001) and S100β (P<0.05) expression in injured nerve tissue.Conclusion Mito@LNP markedly enhanced repair and functional recovery after facial nerve crush injury in rats by improving mitochondrial delivery efficiency, and exhibited superior efficacy compared with free mitochondria.

     

/

返回文章
返回